Clinical trial

A Long Term Prospective Follow Up Study For The CATO Study (SAS30018/SER9702)

NCT00441675 · GlaxoSmithKline, Industry · Completed

Key facts

NCT number NCT00441675
Title A Long Term Prospective Follow Up Study For The CATO Study (SAS30018/SER9702)
Official title A Long Term Follow up Study for a Comparison of Stepwise Treatment of Asthmatic Children With Salmeterol/Fluticasone Propionate Combination Product (SERETIDE®) and/or Fluticasone Propionate (FLIXOTIDE (TM)) Based on PD20 Methacholine and Symptoms or Based on Symptoms Only.
Lead sponsor GlaxoSmithKline, Industry
Status Completed
Study type Observational
Conditions Asthma
Intervention type Procedure
Interventions Symptom Score, Symptom Score and PD20
Enrollment 137
Start date Jan 1, 2007
Primary completion Oct 1, 2007
Completion Oct 1, 2007
First posted Mar 1, 2007
Last update posted Mar 19, 2012
Countries Netherlands

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies